Features
Management of Hyphema After Trabecular MIGS
Appropriate monitoring ensures best outcomes.
By Declan Kirk, MD, Carl Pellerin, MD, Matt Porter, MD, et al.
Emerging Nonsurgical Glaucoma Treatment Options
Options to lower IOP and those independent of IOP are under evaluation.
By Tanner J. Ferguson, MD, Kristin Mohr, OD
Weighing the Options for MIGS
Continued growth in the MIGS space has brought with it uncertainty over choice.
By Iqbal K. Ahmed, MD, FRCSC
Prospects for Optic Nerve Regeneration and Vision Restoration in Patients With Glaucoma
Vision restoration for optic neuropathy may one day be feasible.
By Thomas V. Johnson, MD, PhD
Surgical Pearls for the Streamline Surgical System
Attention to nuances of the device can ensure smooth adoption.
By Galia Deitz, MD, Leonard K. Seibold, MD
Web Exclusives
Perspectives on Glaucoma Training Programs
Rapid evolution of glaucoma surgical techniques necessitates trainee exposure to modern minimally invasive glaucoma surgery.
By Shivani S. Kamat, MD, Lorraine M. Provencher, MD
Departments
From the Editor: Medicare Contractors Attack Vulnerable Glaucoma Patients
Proposed changes encourage systematic inequality for glaucoma patients.
By Nathan Radcliffe, MD
Product Spotlight: Minimally Invasive, Implant-free MIGS
Omni surgical system amplifies ergonomics and surgical confidence.
By Karen Appold, contributing writer
News
FDA Approves Mydcombi Mydriasis Spray on Optejet Platform
By Conni Koury, contributing editor
First Nondegradable, Synthetic Tissue Substitute for Ophthalmic Surgery Cleared
By Conni Koury, contributing editor
FDA Accepts NDA for iDose TR
By Conni Koury, contributing editor
Bimatoprost-eluting Contact Lens Validated in Trial
By Conni Koury, contributing editor
Norlase Receives FDA 510(k) Clearance, CE Mark for ECHO
By Conni Koury, contributing editor
Two-Year Omni Data Show Sustained Reductions in IOP, Medication Use
By Conni Koury, contributing editor
First-in-Class, Dual-MOA Small-molecule Glaucoma Treatment Met Primary Endpoints in Phase 2a Trial
By Conni Koury, contributing editor
Standalone iStent Infinite Effective for Uncontrolled Glaucoma
By Conni Koury, contributing editor
SpyGlass Completes Financing to Support Drug-delivery Platform Trials
By Conni Koury, contributing editor
Photopic Negative Response Using RETeval System Provides Objective RNFL Information
By Conni Koury, contributing editor
Glaukos and Radius XR Partner on Wearable Diagnostic
By Conni Koury, contributing editor
AI Robot Can Assess Patients for Glaucoma
By Conni Koury, contributing editor
Omidenepag Isopropyl Drops Effective, May Have Role
By Conni Koury, contributing editor
Clobetasol Nanoemulsion Safe, Effective for Postop Pain, Inflammation in Phase 3 Study
By Conni Koury, contributing editor